- Home
- NRDY vs OBIO Comparison
NRDY vs OBIO Comparison
Compare NRDY & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- OBIO
- Stock Information
- Founded
- NRDY 2007
- OBIO 2017
- Country
- NRDY United States
- OBIO United States
- Employees
- NRDY N/A
- OBIO N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- NRDY Technology
- OBIO Health Care
- Exchange
- NRDY Nasdaq
- OBIO Nasdaq
- Market Cap
- NRDY 220.5M
- OBIO 200.1M
- IPO Year
- NRDY N/A
- OBIO N/A
- Fundamental
- Price
- NRDY $1.98
- OBIO $4.58
- Analyst Decision
- NRDY Hold
- OBIO Strong Buy
- Analyst Count
- NRDY 8
- OBIO 4
- Target Price
- NRDY $2.35
- OBIO $15.75
- AVG Volume (30 Days)
- NRDY 3.5M
- OBIO 53.8K
- Earning Date
- NRDY 11-07-2024
- OBIO 11-12-2024
- Dividend Yield
- NRDY N/A
- OBIO N/A
- EPS Growth
- NRDY N/A
- OBIO N/A
- EPS
- NRDY N/A
- OBIO N/A
- Revenue
- NRDY $197,325,000.00
- OBIO $2,647,000.00
- Revenue This Year
- NRDY N/A
- OBIO $12.39
- Revenue Next Year
- NRDY $2.86
- OBIO $120.99
- P/E Ratio
- NRDY N/A
- OBIO N/A
- Revenue Growth
- NRDY 9.55
- OBIO N/A
- 52 Week Low
- NRDY $0.73
- OBIO $4.22
- 52 Week High
- NRDY $3.60
- OBIO $10.46
- Technical
- Relative Strength Index (RSI)
- NRDY 72.54
- OBIO 43.91
- Support Level
- NRDY $1.46
- OBIO $4.78
- Resistance Level
- NRDY $2.18
- OBIO $5.84
- Average True Range (ATR)
- NRDY 0.25
- OBIO 0.42
- MACD
- NRDY 0.02
- OBIO -0.04
- Stochastic Oscillator
- NRDY 58.23
- OBIO 24.24
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.